Low-Dose Gemcitabine Treatment Enhances Immunogenicity and Natural Killer Cell-Driven Tumor Immunity in Lung Cancer

Overview of attention for article published in Frontiers in immunology, February 2020

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 46 Dimensions

Readers on

mendeley: 40 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 36,374 followers.

RT @FrontImmunol: New Research: Low-Dose Gemcitabine Treatment Enhances Immunogenicity and Natural Killer Cell-Driven Tumor Immunity in Lun…

31 Mar 2020

Reply Repost Favourite

New Research: Low-Dose Gemcitabine Treatment Enhances Immunogenicity and Natural Killer Cell-Driven Tumor Immunity in Lung Cancer: Gemcitabine has been used as first-line chemotherapy against lung cancer, but many patients experience cancer… https://t.co/f

31 Mar 2020

Reply Repost Favourite

Low-Dose Gemcitabine Treatment Enhances Immunogenicity and Natural Killer Cell-Driven Tumor Immunity in Lung Cancer. by Zhang X, Wang D, Li Z, Jiao D, Jin L, Cong J, Zheng X, Xu L https://t.co/GmajAaF0qM

13 Mar 2020

Reply Repost Favourite

https://t.co/lk3HRYqYCf

29 Feb 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.